UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000060381
Receipt number R000069074
Scientific Title Prevalence of osteopenia and osteoporosis in under 40 years female and examination of related factors
Date of disclosure of the study information 2026/01/19
Last modified on 2026/01/19 09:56:02

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prevalence of osteopenia and osteoporosis in under 40 years female patients and examination of related factors

Acronym

Prevalence of osteopenia and osteoporosis and related factors

Scientific Title

Prevalence of osteopenia and osteoporosis in under 40 years female and examination of related factors

Scientific Title:Acronym

Prevalence of osteopenia and osteoporosis and related factors

Region

Japan


Condition

Condition

Osteopenia, Osteoporosis

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To elucidate the prevalence of osteopenia and osteoporosis in under 40 years female patients and to investigate the relationship with fracture risk factors, lifestyle habits, and dietary habits.

Basic objectives2

Others

Basic objectives -Others

epidemiology

Trial characteristics_1

Exploratory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

Prevalence of osteopenia and osteoporosis and related factors

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

39 years-old >=

Gender

Female

Key inclusion criteria

1. Female patients aged 20 to 39 who visit the clinic conducting this research
2. Patients who were offered BMD testing and requested the measurement

Key exclusion criteria

1. Patients under 20 years of age
2. Patients who did not complete the questionnaire

Target sample size

150


Research contact person

Name of lead principal investigator

1st name Yuki
Middle name
Last name Takeda

Organization

Kawasaki Orthopedic and Rheumatology Clinic

Division name

Kawasaki Orthopedic and Rheumatology Clinic

Zip code

210-0007

Address

14-6 Ekimae-honcho, Kawasaki Ward, Kawasaki City, Kanagawa Prefecture, Japan

TEL

044-222-3737

Email

y_takeda14@yahoo.co.jp


Public contact

Name of contact person

1st name Yuki
Middle name
Last name Takeda

Organization

Kawasaki Orthopedic and Rheumatology Clinic

Division name

Kawasaki Orthopedic and Rheumatology Clinic

Zip code

210-0007

Address

14-6 Ekimae-honcho, Kawasaki-ku, Kawasaki-shi, Kanagawa, Japan

TEL

044-222-3737

Homepage URL


Email

y_takeda14@yahoo.co.jp


Sponsor or person

Institute

Kawasaki Orthopedic and Rheumatology Clinic

Institute

Department

Personal name



Funding Source

Organization

Japan Osteoporosis Society (Sponsored by Amgen)

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Public Health Research Foundation, Institutional Review Board

Address

1-1-7 Nishiwaseda, Shinjuku City, Tokyo, Japan

Tel

+81-3-5287-5070

Email

rinri@phrf.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 01 Month 19 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2025 Year 12 Month 11 Day

Date of IRB

2025 Year 12 Month 24 Day

Anticipated trial start date

2026 Year 01 Month 19 Day

Last follow-up date

2027 Year 10 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

None


Management information

Registered date

2026 Year 01 Month 16 Day

Last modified on

2026 Year 01 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000069074